Tamoxifen enhances the control of acromegaly treated with somatostatin analog lanreotide. | |
MedLine Citation:
|
PMID: 21221819 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
We present the case of a 51-year old female patient with acromegaly that was resistant to somatostatin analogs and dopamine agonists. The patient was diagnosed with breast cancer requiring treatment with the anti-estrogen tamoxifen. Prior to initiating the treatment with tamoxifen, the IGF-I level was very high at 415% of the upper limit of normal for the patient's age and sex. During the tamoxifen treatment, the level of IGF-I dropped spectacularly down to normal levels. This observation highlights the effect of an anti-estrogen treatment in certain female patients with acromegaly. |
Authors:
|
Jean-Christophe Maiza; Stéphane Castillo-Ros; Maria Matta; Antoine Bennet; Philippe Caron |
Related Documents
:
|
7683259 - Assessment of glomerular charge selectivity in man by differential clearance of isoamyl... 17517249 - Nephropathy advancing to end-stage renal disease: a novel complication of lysinuric pro... 9729649 - Spontaneous cellulitis in adults with idiopathic nephrotic syndrome. 16522659 - Vascular diseases and their risk factors in iga nephropathy. 17044469 - Clinical characteristics and histopathological findings in 120 iga nephropathy patients... 6424039 - Strong association of idiopathic membranous nephropathy with hla-dr2 and mt1 in japanese. 1462019 - Radiological evidence of progression of bronchiectasis. 3925159 - The contribution of sonographic evaluation of ovarian size in patients with polycystic ... 25427539 - Regulation of blood coagulation factors xi and xii in patients with acute and chronic c... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-1-8 |
Journal Detail:
|
Title: Pituitary Volume: - ISSN: 1573-7403 ISO Abbreviation: - Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2011-1-11 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9814578 Medline TA: Pituitary Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Endocrinology and Metabolic Diseases, CHU Larrey, 24 Chemin de Pourvouville, TSA 30030, 31059, Toulouse Cedex 9, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
MeSH Terms | |
Descriptor/Qualifier:
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Conversion of daily pegvisomant to weekly pegvisomant combined with long-acting somatostatin analogs...
Next Document: Assessment of bioburden on human and animal tissues: Part 1-Results of method development and valida...